1 (2)
15.01.2015
Mette Elstrøm
Cand. Pharm.
Danish Health and Medicines Authority
Medicines Control & Inspection
Company Authorisations & Distribution
Dnro Fimea
003421/00.04.05/2014
Medicinal cannabis – Questions asked by the national parliament of Denmark; ref. 2014122007
Dear Mme Elstrøm,
Thank you for contacting the Finnish Medicines Agency (later Fimea) on
the matter of medicinal cannabis. We have been in close cooperation on
this matter with your Agency already earlier. To the questions you raised
Fimea would like to give the following answers:
1. What kind of cannabis products has been imported?
There is three different herbal cannabis products imported to Finland. The
trade names for these are Bedrocan, Bediol and Bedica.
2. In what amount has cannabis been imported?
The annual quotas for cannabis in Finland have been requested from th In-
ternational Narcotics Control Board (INCB). The estimates for cannabis
during the past ten years have been the following (in grams):
Year
Estimate for cannabis
2005
1
2006
1142
2007
602
2008
4050
2009
20047
2010
20050
2011
20050
2012
25000
2013
35000
2014
40255
The imports are primarily the above mentioned products and from the
Netherlands. The actual import has increased, however the estimates have
never been reached.
3. How are the imported cannabis controlled?
The imported herbal cannabis is for compassionate use and all is for speci-
fied patients. The products are dispensed from pharmacy, which only are
few. The control is similar than to any other medicinal product containing
narcotic substance.
4. For which purpose are the imported cannabis used?
The herbal cannabis is for compassionate use only. The indications ac-
cepted have primarily been to reducing spasticity and pain in patients with
Lääkealan turvallisuus- ja kehittämiskeskus | Säkerhets- och utvecklingscentret för läkemedelsområdet | Finnish Medicines Agency
PL 55, 00034 FIMEA | Puh. 029 522 3341 | [email protected] | www.fimea.fi
| Y-tunnus 0921536-6